Li, T.; Huang, W.; Wu, Z.; Wang, Y.; Wang, Q.; Wang, Z.; Liu, Q.; Liu, J.; Wang, S.; Ding, X.;
et al. Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study. Curr. Oncol. 2022, 29, 3950-3961.
https://doi.org/10.3390/curroncol29060316
AMA Style
Li T, Huang W, Wu Z, Wang Y, Wang Q, Wang Z, Liu Q, Liu J, Wang S, Ding X,
et al. Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study. Current Oncology. 2022; 29(6):3950-3961.
https://doi.org/10.3390/curroncol29060316
Chicago/Turabian Style
Li, Tiankuan, Wei Huang, Zhiyuan Wu, Yong Wang, Qingbing Wang, Ziyin Wang, Qin Liu, Jingjing Liu, Shenjie Wang, Xiaoyi Ding,
and et al. 2022. "Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study" Current Oncology 29, no. 6: 3950-3961.
https://doi.org/10.3390/curroncol29060316
APA Style
Li, T., Huang, W., Wu, Z., Wang, Y., Wang, Q., Wang, Z., Liu, Q., Liu, J., Wang, S., Ding, X., & Wang, Z.
(2022). Percutaneous Ablation of Hepatic Tumors at the Hepatocaval Confluence Using Irreversible Electroporation: A Preliminary Study. Current Oncology, 29(6), 3950-3961.
https://doi.org/10.3390/curroncol29060316
